Foresite Capital Founded 2011
Founders Jim Tananbaum
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 43
Average round size
info
The average size of a deal this fund participated in
$75M
Portfolio companies 43
Rounds per year 4.30
Lead investments 19
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits -
Key employees -
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity
Areas of investment
Finance
Financial Services
Venture Capital
Summary

In 2011 was created Foresite Capital, which is appeared as VC. The main department of described VC is located in the San Francisco. The company was established in North America in United States.

The current fund was established by Jim Tananbaum. The overall number of key employees were 11.

The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Foresite Capital, startups are often financed by Venrock, Third Rock Ventures, Paladin Capital Group. The meaningful sponsors for the fund in investment in the same round are Cormorant Asset Management, ARCH Venture Partners, Paladin Capital Group. In the next rounds fund is usually obtained by Paladin Capital Group, Merieux Developpement, EcoR1 Capital.

The higher amount of exits for fund were in 2015. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in 7-12 investment rounds annually. The real fund results show that this VC is 9 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 50 - 100 millions dollars. The typical startup value when the investment from Foresite Capital is more than 1 billion dollars. Opposing the other organizations, this Foresite Capital works on 12 percentage points more the average amount of lead investments.

Among the various public portfolio startups of the fund, we may underline AveXis, Intarcia Therapeutics, Audentes Therapeutics Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Health Care, Genetics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Sequenta
Biotechnology
Health Diagnostics
Medical
Series C
20M02 Jul 2013 Panama, San Francisco
Pharvaris
Biotechnology
Life Science
Pharmaceutical
Series C
80M18 Nov 2020 Switzerland, Zug
Tarsa Therapeutics
Biotechnology
Medical
Medical Device
Series B
7M29 May 2014 United States, Philadelphia
evonetix
Biopharma
Biotechnology
Life Science
Series B
30M02 Mar 2020 United Kingdom, Uttlesford
Insitro
Biotechnology
Life Science
Machine Learning
Pharmaceutical
Series A
02 May 2018 United States, South San Francisco
DNAnexus
Bioinformatics
Biotechnology
Cloud Computing
Genetics
Medical
Series F
68M06 Feb 2019 United States, Mountain View
Insitro
Biotechnology
Life Science
Machine Learning
Pharmaceutical
Series A
100M16 Apr 2019 United States, South San Francisco
Jounce Therapeutics
Biotechnology
Drug Discovery
Pharmaceutical
Therapeutics
Series B
56M23 Apr 2015 United Kingdom, Cambridge
Decibel Therapeutics
Biotechnology
Medical Device
Therapeutics
Series D
82M09 Nov 2020 United Kingdom, Cambridge
Kinnate Biopharma
Biopharma
Biotechnology
Health Care
Medical
Therapeutics
Series C
98M26 Aug 2020 United States, San Diego
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Foresite Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: